News
Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt ...
3d
GlobalData on MSNAlvotech expands biosimilars capabilities with Ivers-Lee acquisitionIvers-Lee’s assembly and packaging capabilities will be integrated into Alvotech's Technical Operations division.
Linda Jónsdóttir Linda Jonsdottir, Alvotech's new Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech ...
Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...
Alvotech acquires Swiss packaging firm Ivers-Lee to boost biosimilar production capacity ahead of three 2025 launches.
Joel Morales, who has served as CFO of Alvotech since 2020, based in the U.S., has decided to step down. He will continue supporting Alvotech in an advisory capacity to ensure a smooth transition.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Alvotech (NASDAQ:ALVO) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, Alvotech ...
Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...
19d
Pharmaceutical Technology on MSNBayer’s Eylea market grip set to slip as Alvotech biosimilar closes inAn EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.
Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred ...
--Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results